Combined aerobic and resistance training
Studies of combined aerobic and resistance training in people
172 studies gave combined aerobic and resistance training to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on functional capacity6-minute walking distance between-group p=0.55 | Randomized trial12 weeks | 13 peopleParticipants with severe obesity after bariatric surgery | Research Square, Nov 20, 2026 |
up: Increases placental KlothoAdjusted mean difference approximately 101 pg/mL versus usual care | Trialearly-mid pregnancy until birth | 76 peopleWomenPregnancy | medRxiv, Nov 2, 2026 |
up: Increases peak oxygen uptake+4.0±3.1 mL/min/kg no change: Has no effect on supine heart rate76±9 versus 74±9 beats/min; p=0.218 down: Decreases heart rate increase upon standing33±12 versus 25±10 beats/min; p=0.002 | Trial3 months | 31 peopleBoth28±7 years at enrollmentPostural orthostatic tachycardia syndrome | AHA Scientific Sessions 2026 abstract, Nov 2, 2026 |
down: Decreases fasting glucose up: Increases progressive sperm motilityBetween-group difference in change: 4.55 percentage points, 95% CI 3.66 to 5.44 up: Increases total testosterone | Trial12 weeks | 34 peopleMen18–24 yearsHealthy men | Journal of clinical medicine, Oct 29, 2026 |
down: Decreases blood pressure down: Decreases redox-related DNA methylation | Trial14 weeks | 45 peopleWomenmiddle-aged and olderMidlife adults; Older adults; physically inactive women; single-arm study | Antioxidants (Basel, Switzerland), Oct 27, 2026 |
down: Decreases body fat percentageAdjusted difference −2.15 percentage points; 95% CI −2.75 to −1.56 up: Increases VO2MAX down: Decreases insulin resistance | Randomized trial8 weeks | 30 peopleWomen20–39 yearsNormal-weight obesity | Metabolites, Oct 26, 2026 |
down: Decreases syncope events0–3 events in the interval group vs 0–4 in the continuous group | Randomized trial6-week training; 6-month follow-up | 48 peopleBothVasovagal syncope type 1 without cardioinhibition and confirmed autoimmune disease | ESC Congress 2026 abstract, Oct 26, 2026 |
up: Improves lower limb muscle strength up: Improves quality of life | Randomized trial8 weeks | 68 peopleBreast cancer patients with chemotherapy-induced peripheral neuropathy | Pain management nursing : official journal of the American Society of Pain Management Nurses, Oct 22, 2026 |
up: Improves physical function up: Improves body composition | Trial12 weeks | 84 peoplemean age 83.13 ± 7.63 yearsOlder adults; institutionalized older adults | Healthcare (Basel, Switzerland), Oct 21, 2026 |
| Randomized trial12 weeks | 54 peopleWomen≥65 yearsOlder adults; obesity | Journal of obesity & metabolic syndrome, Oct 20, 2026 | |
down: Decreases 24-hour systolic average real variability−2 ± 1 mmHg | Randomized trial12 weeks | 20 peopleBoth50–80 yearsMidlife adults; Older adults; hypertension; within-group change over time | Frontiers in rehabilitation sciences, Oct 19, 2026 |
up: Increases flow-mediated vasodilation up: Increases nitric oxide no change: Has no effect on nitric oxide | Randomized trial12 weeks | 20 peopleolder adultsOlder adults; type 2 diabetes; comparison with baseline | Frontiers in endocrinology, Oct 16, 2026 |
down: Decreases 24-hour mean glucoseβ = -0.513; Bonferroni-corrected p = 0.017 up: Increases time in range | Randomized trial24 hours | 23 peopleolder adultsOlder adults; type 2 diabetes mellitus; exploratory analysis | Journal of science and medicine in sport, Oct 15, 2026 |
down: Decreases fat mass up: Increases muscle mass | Randomized trial12 weeks | 13 peopleWomenPostmenopausal women | Experimental gerontology, Oct 10, 2026 |
down: Decreases frailty up: Improves quality of life | Randomized trial12 weeks | 120 peopleolder adultsOlder adults; frailty syndrome | Chinese Journal of Gerontology, Oct 8, 2026 |
up: Improves handgrip strength+3.78 kg up: Increases rectus femoris cross-sectional area down: Decreases fat tissue mass40.3 to 36.7 kg | Treated cohortsix-month | 17 peopleClinically stable adults with end-stage kidney disease (ESKD) on maintenance hemodialysis | Research Square, Sep 30, 2026 |
down: Decreases triglycerideMD -0.255, 95% CI -0.355 to -0.156 | Review of trials | 4,483 people pooledGeneral population | Metabolites, Sep 17, 2026 |
down: Decreases body fat percentage-2.04 percentage points, 95% CI -2.94 to -1.14 up: Improves estimated VO2max | Randomized trial12 weeks | 108 peoplewomen40–77 yearsWomen aged 40–77 years | Journal of the International Society of Sports Nutrition, Sep 14, 2026 |
| Randomized trial16 weeks | 42 peopleWomenBreast cancer survivors | Cancer treatment and research communications, Sep 7, 2026 | |
up: Improves health-related quality of lifeMD 7.96, 95% CI 2.95–12.96 up: Improves exercise capacityMD 51.10, 95% CI 16.04–86.16 | Review of trials8 to 96 weeks | 806 people pooledAdult male patientsProstate cancer patients receiving androgen deprivation therapy (ADT) | Frontiers in oncology, Aug 17, 2026 |
| Randomized trial8 weeks | 16 peopleWomen | Research Square, Aug 12, 2026 | |
| Randomized trial12 weeks | 11 peopleMen23-32 yearsObesity | BMC sports science, medicine & rehabilitation, Aug 12, 2026 | |
up: Improves postural stability+6.5 vs +2.7 points, partial eta-squared=0.58 up: Improves dual-task Timed Up and Go performance-5.2 vs -1.5 s, partial eta-squared=0.55 | Randomized trialeight weeks | 15 people55-75 yearsOlder adults; in older adults with cognitive impairment | International Journal of Advanced Research and Multidisciplinary Trends (IJARMT), Aug 11, 2026 |
no change: Has no effect on C-reactive proteinSMD = −0.42, 95% CrI: −1.26 to 0.42 | Review of trials6 weeks to 12 months | 2,836 people pooledmean age of 76.98 yearsPredominantly older adults with chronic disease, with the remainder comprising healthy older adults and populations with mixed or unspecified health status | Frontiers in medicine, Aug 6, 2026 |
up: Improves cardiometabolic fitness down: Decreases very-long-chain ceramides down: Decreases ceramide | Randomized trial12 weeks | 29 peopleMen and postmenopausal women with overweight or obesity and type 2 diabetes | Diabetologia, Aug 5, 2026 |
down: Decreases HbA1cMD = -1.05% down: Decreases fasting blood glucoseMD = -1.44 mmol/L down: Decreases 2-hour postprandial glucoseMD = -3.15 mmol/L | Review of trials | 2,461 people pooledBothat least 60 yearsOlder adults; older adults with type 2 diabetes mellitus | Frontiers in endocrinology, Jul 15, 2026 |
up: Increases adiponectinmean change 1.23 (95% CI 0.98-1.49) NMSE; 0.86 (95% CI 0.31-1.40) MSE; d = 1.04 and 0.71 up: Increases FGF21mean change 16.75 (95% CI 5.46-28.05); d = 0.40 down: Decreases FGF21mean change -15.91 (95% CI -28.35 to -3.48); d = -0.33 | Randomized trial10 weeks | 60 peopleWomen75.2 ± 4.3 yearsOlder adults; in both exercise groups (NMSE and MSE) | The journal of nutrition, health & aging, Jul 4, 2026 |
no change: Has no effect on PAI-124.69±16.77 to 29.81±8.83; p=.1667 no change: Has no effect on C-reactive protein0.91±1.64 to 0.41±0.16; p=.2198 no change: Has no effect on fasting blood glucose | Trial24 weeks | 15 peopleWomenmean 56.27 yearsMidlife adults; Postmenopausal women; Postmenopausal women with regular physical activity experience; single-group before-and-after comparison | Journal of Coaching Development, Jun 30, 2026 |
no change: Has no effect on arterial stiffness no change: Has no effect on hemodynamic parameters | Randomized trial16 weeks | Older adults; previously trained grade 1 hypertension | Canadian geriatrics journal : CGJ, May 29, 2026 |
up: Increases adropinp = 0.03 down: Decreases cardio-ankle vascular indexp = 0.01 | Randomized trial12 weeks | 30 peopleWomen50-65 yearsOlder adults; Postmenopausal women; type 2 diabetes | BMC sports science, medicine & rehabilitation, May 14, 2026 |
down: Decreases serum cadmium-0.056 μg/L (-63%) | Trial14 weeks | 32 peopleWomen50-70 yearsOlder adults; lower aerobic fitness | Epigenomics, May 14, 2026 |
no change: Has no effect on chemotherapy induced peripheral neuropathy no change: Has no effect on cancer-related fatigue no change: Has no effect on handgrip strength | Randomized trial8 weeks | 27 peopleColorectal cancer patients receiving chemotherapy | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, Apr 30, 2026 |
down: Decreases fat mass-11.9% ± 5.7% vs. -10.1% ± 4.9%; ES -0.64 [-0.85, -0.40] | Randomized trial26 weeks | 58 peopleBoth18-65 yearsFollowing metabolic bariatric surgery | Journal of cachexia, sarcopenia and muscle, Apr 30, 2026 |
down: Decreases body weight | Randomized trial12 weeks | 45 peopleWomen50–65 yearsPostmenopausal women; Midlife adults; Older adults; overweight or obesity | Exploration of Endocrine and Metabolic Diseases, Apr 30, 2026 |
down: Decreases tremor up: Improves six-minute walk test down: Decreases vitamin D3 | Trial8 weeks | 28 peopleParkinson's disease | NeuroRehabilitation, Apr 10, 2026 |
down: Decreases triglyceride | Randomized trial12 weeks | 83 peopleWomen40–77 yearsMidlife adults; Older adults; larger TG decrease than with resistance training | Research Square, Mar 25, 2026 |
up: Increases estimated glomerular filtration rate5.2 mL/min/1.73 m2 (95%CI: 0.9-9.5, p = 0.019) no change: Has no effect on albumin | Randomized trial9 months | 136 peopleBothaged 41-87 yearsMidlife adults; Older adults; The oldest old; type 2 diabetes without kidney disease | Diabetes & metabolic syndrome, Mar 24, 2026 |
down: Decreases body weight up: Improves muscle strength up: Increases non-exercise activity thermogenesis | Randomized trialthrough week 32 | 57 peopleFifty-seven womenaverage age of 65.3 ± 3.4 yearsHealthy, nonsmoking, sedentary older women free of metabolic diseases | European journal of applied physiology, Mar 24, 2026 |
down: Decreases CD8+ naive T cells down: Prevents insulin | Trial12 weeks | 11 peoplewomen49.1 ± 14.4 yearsWomen with early-stage breast cancer undergoing (neo)adjuvant treatment | Research Square, Mar 20, 2026 |
up: Increases maximal oxygen uptakeP < .01 | Trialfour years | 25 peopleMen66 ± 7 yearsOlder adults | The American journal of medicine, Mar 9, 2026 |